TCRT
Alaunos Therapeutics Inc.
NASDAQ · Healthcare
Alaunos Therapeutics Inc. annual/quarterly net income history and growth rate from 2011 to 2026. Net income is the total earnings of a company after all expenses, including taxes and interest, have been deducted from total revenues.
- Alaunos Therapeutics Inc. net income for the quarter ending March 31, 2026 was -1.0 M, a 6.24% decrease year-over-year.
- Alaunos Therapeutics Inc. net income for the twelve months ending March 31, 2026 was -4.3 M, a 65.45% decrease year-over-year.
- Alaunos Therapeutics Inc. annual net income for 2025 was -4.2 M, a 10.75% decrease from 2024.
- Alaunos Therapeutics Inc. annual net income for 2024 was -4.7 M, a 0.00% increase from 2023.
- Alaunos Therapeutics Inc. annual net income for 2023 was -4.7 M, a 87.60% decrease from 2022.
- Alaunos Therapeutics Inc. annual net income for 2022 was -37.7 M.
Net Income
TRAILING 12 MONTHS · $B
QUARTERLY · $B
YEAR-OVER-YEAR GROWTH · %